SMMT
NASDAQ · Biotechnology
Summit Therapeutics Inc
$14.25
-0.03 (-0.21%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-21.44%
1Y
-31.88%
YTD
-18.66%
Open$13.93
Previous Close$14.28
Day High$14.81
Day Low$13.93
52W High$30.98
52W Low$12.55
Volume—
Avg Volume7.36M
Market Cap10.67B
P/E Ratio—
EPS$-1.60
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$16.75
Below
SMA 200
$20.83
Below
RSI (14)
54
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Buy
24 analysts
Price Target
+1,276.0% upside
Current
$14.25
$14.25
Target
$196.08
$196.08
$141.53
$196.08 avg
$244.39
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.10B | 1.08B | 883.89M |
| Net Income | 169.72M | 168.86M | 142.65M |
| Profit Margin | 15.4% | 15.6% | 16.1% |
| EBITDA | 286.46M | 306.19M | 235.37M |
| Free Cash Flow | 170.10M | 157.58M | 108.43M |
| Rev Growth | -3.6% | +10.5% | -9.8% |
| Debt/Equity | 1.16 | 1.05 | 1.18 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |